AstraZeneca launches patented life-saving heart drug in India Express Pharma Dr Paurus Irani, Vice President Medical & Regulatory Affairs, AstraZeneca Pharma India said, "With over 40 lakh people affected by ACS in India each year, Brilinta gives cardiologists a new and effective treatment to help reduce the rate of heart ... |